NorthWest Biotherapeutics Inc (NWBO)

[Nick119]

I e-mailed them already on this. I got no response:

Dave, Les,

Can I ask you both a direct question regarding why NWBO has not updated the endpoints for the clinicaltrials.gov page for the DCVax-L trial? I've put a tremendous amount of effort, including writing an in-depth article on the subject, into defending the stance of the trial endpoints on social media platforms. Trying to communicate that these new endpoints, the ones described in yesterday's presentation, are the current and latest endpoints by which the results will be evaluated. It hurts the company and investors to allow the naysayers the ability to take the trial results and then link to the outdated clinicaltrial.gov page and say we missed the endpoints. Only the more diligent investors will be able to follow that the trial endpoints have been updated.

That being said, what is the rationale towards not updating these endpoints? I understand that you are likely embargoed by the journal at this point and not wanting to put yourselves in any jeopardy of being published, but this could have been done a long time ago. Just curious as to the rationale here.

Appreciate your support.